News & Articles

The trial demonstrates that first-line pembrolizumab treatment improved overall and progression-free survival rates in patients with metastatic nonsquamous non-small cell lung cancer

The primary endpoint for first-line nivolumab-ipilimumab combo trial indicates improved progression-free survival in patients with advanced non-small cell lung cancer

Expansion of circulating tumor-specific T cells after nivolumab treatment suggests systemic antitumor immunity in patients with resectable lung cancer

The FT819 CAR T cell line has the potential to be mass-produced, stored, and made readily available for cancer immunotherapy

A recent study from University of Edinburgh aims to pinpoint genes that may be associated with depression

MMI launch their latest solution at the AACR meeting in Chicago: CellScan

Crizotinib yielded a high objective response rate for adult patients with ALK-positive Inflammatory myofibroblastic tumor, and a 100 percent disease control rate

Research reveals that acquired HER2 mutations confer resistance to hormone therapy in ER-positive metastatic breast cancer

Alexandra Knauer from KNAUER Wissenschaftliche Geräte swoops the award with her excellency in leadership and entrepreneurship

New discoveries on devil facial tumor suggest that human cancer drugs may reduce the cancer mortality rate of Tasmanian devils - an endangered species naive to the Australian island of Tasmania

Studies suggest that large concentrations of sulfites and bisulfites in shallow lakes may have set the stage for Earth’s first biological molecules.

The OEM deal aims to bring new improvements to existing equipment